Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Stocks Surge at Midday: Eledon and Avid Bioservices on the Rise

Reading Time: < 1 minute

Eledon Pharmaceuticals Inc. (Nasdaq: ELDN) experienced a significant 12% jump in its share price, reaching $3.122 per share and boasting a market cap of $118 million. The Irvine-based biopharmaceutical company has seen its trading volume double the daily average, indicating heightened investor interest. This surge comes as shares of Eledon have tripled since hitting a 52-week low of $1.07 back in December.

In a similar vein, Avid Bioservices Inc. (Nasdaq: CDMO) also saw a positive uptick, rising 2.8% to $9.46 per share with a market cap of $601 million. The Tustin-based contract drug manufacturer has experienced a 37% increase in its shares since reporting its third-quarter financial results on April 24.

On the indexes front, gold prices saw a 1.2% gain, reaching $2,414 per ounce. This movement in the precious metal market reflects ongoing shifts in investor sentiment and economic conditions.

Overall, the healthcare sector continues to be a focal point for investors, with companies like Eledon Pharmaceuticals and Avid Bioservices showcasing strong performance and market interest. As the industry evolves and responds to changing demands, these companies are positioning themselves for growth and success in the competitive biopharmaceutical landscape.

Taylor Swifts New Album Release Health issues from using ACs Boston Marathon 2024 15 Practical Ways To Save Money